Renal Effects of DPP-4 Inhibitor Linagliptin in Type 2 Diabetes

Clinical trial NCT02106104 · COMPLETED

Trial details

NCT number: NCT02106104
Sponsor: Amsterdam UMC, location VUmc
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2014-03-01
Primary completion: 2016-04-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.